Congress Adopts New User Fee Program

July 2, 2002
Jill Wechsler
Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor,

Pharmaceutical Technology, Pharmaceutical Technology-07-02-2002, Volume 26, Issue 7

To fund expanded FDA operations designed to streamline drug development and approval, FDA and industry representatives have negotiated the Prescription Drug User Fee Act III.